Effect of rt-PA intravenous thrombolysis on the prognosis of patients with minor ischemic stroke.
Aged
Brain Ischemia
/ blood
C-Reactive Protein
/ metabolism
Female
Fibrinolytic Agents
/ administration & dosage
Humans
Infusions, Intravenous
Ischemic Stroke
/ blood
Male
Middle Aged
Neutrophils
/ drug effects
Prognosis
Thrombolytic Therapy
/ methods
Tissue Plasminogen Activator
/ administration & dosage
Treatment Outcome
C-reactive protein
Minor ischemic stroke
functional prognosis
intravenous thrombolysis
neutrophil ratio
Journal
Neurological research
ISSN: 1743-1328
Titre abrégé: Neurol Res
Pays: England
ID NLM: 7905298
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
pubmed:
14
4
2021
medline:
8
1
2022
entrez:
13
4
2021
Statut:
ppublish
Résumé
The evidence of rt-PA intravenous thrombolysis in patients with minor ischemic stroke (MIS) is still controversial. This study aims to investigate the effect of rt-PA intravenous thrombolysis on the prognosis of patients with MIS. We continuously enrolled and analyzed patients with MIS admitted into our hospital within 24 h after symptom onset between January 2016 and December 2018, including 96 patients received intravenous thrombolysis within 4.5 h after symptom onset and 84 patients not received intravenous thrombolysis. A favorable long-term outcome was a 90-day mRS score of 0-1. Good short-term outcome was a 7-day NIHSS score of 0 or less than NIHSS onset. There were no statistical differences between two groups of patients' age, gender, history of hypertension, coronary heart disease, atrial fibrillation, smoking, drinking, and baseline NIHSS score. Patients with history of stroke (22.62% vs. 10.42%, Patients with MIS received intravenous thrombolysis may be associated with earlier neurological improvement, but might has no significant effect on long-term prognosis. The level of neutrophil ratio and CRP at admission are risk factors determining the prognosis, which requires further research.
Identifiants
pubmed: 33847231
doi: 10.1080/01616412.2021.1908672
doi:
Substances chimiques
Fibrinolytic Agents
0
C-Reactive Protein
9007-41-4
Tissue Plasminogen Activator
EC 3.4.21.68
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM